Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 Par Value
-
Shares outstanding
-
117M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
44.9M
-
Shares change
-
+5.24M
-
Total reported value, excl. options
-
$385M
-
Value change
-
+$45.2M
-
Number of buys
-
32
-
Number of sells
-
-34
-
Price
-
$8.58
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) as of Q4 2021
91 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value as of Q4 2021.
Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.9M shares
of 117M outstanding shares and own 38.5% of the company stock.
Largest 10 shareholders include EVENTIDE ASSET MANAGEMENT, LLC (3.51M shares), PERCEPTIVE ADVISORS LLC (3.19M shares), TCG Crossover Management, LLC (2.75M shares), BlackRock Inc. (2.7M shares), JANUS HENDERSON GROUP PLC (2.52M shares), COMMODORE CAPITAL LP (2.28M shares), Vivo Capital, LLC (1.92M shares), Candriam Luxembourg S.C.A. (1.87M shares), FRAZIER MANAGEMENT LLC (1.77M shares), and Ghost Tree Capital, LLC (1.7M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.